Home›People›David Amerson
DA

David Amerson

Director at Moximed. Also a director at Calyxo, Relievant MedSystems and X9.

DirectorRoles at 4 startups
Updated Nov 10, 2026·Latest SEC filing Apr 16, 2026·Suggest an edit

About David Amerson

Form D filings for Moximed in 2024 list David Amerson as director.

Form D filings also name David Amerson as a director at Calyxo, Relievant MedSystems and X9.

David Amerson first appears on SEC filings in 2022.

Experience

This experience comes from David Amerson's profile and from SEC filings. For roles taken from filings, the years are when the filings name David Amerson in the role, so the role may have started earlier or lasted longer.

Intrinsic Therapeutics, Inc Current
Board Member
2024 – Present
UROLOGY CARE FOUNDATION INC Current
Board Member
2024 – Present
Moximed, Inc Current
Director
2023 – Present · Fremont, CA
ProVerum Current
Chairman
2022 – Present
Calyxo, Inc. Current
Director
2020 – Present · Pleasanton, CA
Calyxo makes a kidney stone removal system for urologists.
Relievant MedSystems, Inc. Current
Director
2020 – Present · Edina, MN
Revelle Aesthetics, Inc.
Chairman Of The Board- Revelle Aesthetics
2021 – 2024
Palette Life Sciences
Chairman of the Board (Acquired by Teleflex 2023)
2020 – 2023
X9, Inc.
Director
2022 · Wallingford, CT
NeoTract
President and CEO (Acquired by Teleflex June 2017)
2011 – 2020

Key Colleagues at Startups

The people David Amerson works with at each company, as listed on that company's latest Form D.

Calyxo, Inc. · Form D, Apr 16, 2026
Douglas Hughes
Douglas Hughes
Chief Financial Officer and director
Jee Shin
Jee Shin
Founder and Chief Business Officer, director
Joe Catanese
Joe Catanese
President and Chief Executive Officer, director
JG
Ryan Drant
Ryan Drant
Founder and Managing Partner, director
Chris Buchko
Chris Buchko
Chief Administrative Officer
DM
Dana Mead
Director
Moximed, Inc · Form D, Aug 20, 2024
JM
SM
DM
MM
AC
Anton Clifford
Executive officer
James Leech
James Leech
Executive officer
Relievant MedSystems, Inc. · Form D, Mar 30, 2023
RM
Richard Mott
Director
TB
Tyler Binney
President and Chief Executive Officer, director
RM
Ray Baker, MD
Executive officer
CG
Chris Geyen
Executive officer
BA
Brent Ahrens
Director
AT
Art Taylor
Director
RJ
Ross Jaffe
Director
JK
Justin Klein
Director
JL
X9, Inc. · Form D, Dec 1, 2022
JC
John Chang
Executive officer
EB
Earl Bright
Chief Executive Officer and director
JM
TC
Tak Cheung
Director
MK

Sources

  1. SECCalyxo, Inc. Form D, filed Apr 16, 2026
  2. SECMoximed, Inc Form D, filed Aug 20, 2024
  3. SECRelievant MedSystems, Inc. Form D, filed Mar 30, 2023
  4. SECX9, Inc. Form D, filed Dec 1, 2022